v3.26.3
Schedule of Total Purchase Consideration (Details) - Asset Purchase Agreement [Member]
Nov. 20, 2025
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Total purchase consideration $ 10,000,000 [1]
Closing Cash [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Total purchase consideration 3,000,000 [1]
Accelerated Portion of The First Installment [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Total purchase consideration 564,073 [1]
Six Month Installment [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Total purchase consideration 2,435,927 [1]
Twelve Month Installment [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Total purchase consideration 2,000,000 [1]
Technology Development Milestone 1 [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Total purchase consideration 1,000,000 [2]
Technology Development Milestone 2 [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Total purchase consideration $ 1,000,000 [2]
[1] The purchase consideration table above reflects the acquisition-date terms of the Molecule.ai APA. As discussed above, the parties entered into a Second Amendment on May 4, 2026, which modified the remaining payment obligations and was accounted for as a separate debt extinguishment transaction.
[2] These payments were contingent upon the achievement of certain milestones. During the six months ended June 30, 2026, the Technology Development Milestone 1 and 2 were achieved. As a result, the Company remitted $1.75 million of the contingent milestone payments and has $0.25 million due to the Selling Party, which is included in contingent consideration liability on the consolidated balance sheets.